CINCINNATI
, Nov.1, 2005 – The
Procter & Gamble
Company (NYSE:PG) announced
strong top and bottom-line
growth for the July
- September quarter.
The company delivered
sales growth of eight
percent and earnings
per share growth of
10% versus year-ago.
Earnings per share
were $0.77 for the
quarter, $0.01 above
analysts’ consensus
estimates. Earnings
per share increased
15% excluding the one-time
gain of $0.03 from
the sale of the Juice
business in the prior
year.
Executive
Summary
- Unit
volume grew
six percent. Organic
volume, which
excludes acquisitions
and divestitures,
increased seven percent.
Growth was broad-based
across business segments
and geographies.
Beauty, family
health, and household
care each delivered
volume growth of
six percent or greater.
All regions grew
volume during the
period. Developing
markets continued
to set the pace
with volume growing
in the mid-teens.
- Net sales increased
eight percent to
$14.79 billion
behind new product
innovations across
the company. Favorable
exchange rates and
pricing activity
to offset rising
costs each contributed
one percent of growth.
Organic sales, which
exclude the impacts
of acquisitions,
divestitures, and
foreign exchange,
also increased
eight percent.
- Diluted net earnings
per share increased
10 percent to $0.77.
The earnings per
share performance
is especially impressive
considering the impacts
of Hurricanes Katrina
and Rita, rising
energy and commodity
costs, continued
high competitive
spending, and a very
strong base period
with 17 percent EPS
growth.
“We’re off to a good
start with broad-based
organic top-line growth,”
said Chairman of the
Board, President and
Chief Executive A.
G. Lafley. “P&G’s
balanced business and
geographic breadth
has again demonstrated
the ability to deliver
consistent, reliable
net sales and earnings
per share growth in
good and challenging
times alike.”
Quarterly
Discussion
Unit
volume for the July
– September quarter
increased six percent.
Organic volume, which
excludes the impact
of acquisitions and
divestitures, grew
seven percent. Growth
was broad-based with
all regions delivering
year-on-year volume
growth. This reflects
progress on key brands
and countries, with
all of the company’s
top 10 brands and countries
delivering year-to-year
volume growth.
Developing regions
grew volume in the
mid-teens for the period.
Growth came largely
behind new product
innovations and developing
market expansion across
P&G’s line-up of
brands.
Net sales increased
eight percent to $14.79
billion. Pricing contributed
one percent to sales
growth behind actions
taken in various businesses
and geographies that
partially recovered
the impact of higher
commodity costs. Favorable
exchange rates also
contributed one percent
of sales growth. Organic
sales, which exclude
the impacts of acquisitions,
divestitures, and foreign
exchange, increased
eight percent. Growth
came largely behind
new product innovations
across P&G’s portfolio
of brands such as Tide
Coldwater, Tide with
Febreze, Dawn Bleach
Alternative, Naturella
expansion in Central
and Eastern Europe,
Pampers Feel ‘n Learn,
and Charmin Mega-Roll.
Operating earnings
increased 10 percent
to $3.06 billion driven
by volume growth, pricing,
and scale leverage
on overhead expenses.
These benefits were
partially offset by
higher commodity prices
and costs associated
with Hurricane Katrina.
Hurricane Katrina had
a negative impact of
approximately two percent
on the company’s operating
earnings growth due
primarily to disruption
of the coffee business,
write-offs of damaged
inventory and physical
assets, and clean-up
and repair costs.
Net earnings increased
four percent to $2.03
billion. Net earnings
growth trailed operating
earnings growth as
a result of the prior
year impact of the
sale of the Juice business
and higher interest
expense from the previously
announced $18 to $22
billion share repurchase
program. Share repurchase
activity totaled $5.55
billion of P&G
stock during the quarter,
bringing cumulative
repurchases under the
program to $8.57 billion.
Diluted net earnings
per share were $0.77,
an increase of 10 percent,
in-line with operating
earnings growth. The
impact of accelerated
share repurchases,
net of associated interest
and Gillette acquisition
expenses, was neutral
on earnings per share
for the quarter.
Key Financial
Highlights
- Gross
margin was
20 basis points
lower than the
prior year as
higher energy
and material
costs were largely
offset by fixed
cost leverage
from volume growth,
cost savings
efforts and pricing.
Higher commodity
costs hurt gross
margins by over
100 basis points.
- Selling, general
and administrative
expenses (SG&A)
increased six percent
year-over-year, but
decreased as a percentage
of net sales by 60
basis points. This
was primarily driven
by strong sales growth
that was well ahead
of the company’s
long-term target
and outpaced the
increase in SG&A
spending.
- The company’s
operating cash flow
for the quarter was
$2.17 billion, an
increase of 14 percent
compared to the base
period. The improvement
was driven by solid
earnings growth and
the timing of tax
payments versus the
prior year. Free
cash flow, defined
as operating cash
flow less capital
spending, was $1.77
billion. Free cash
flow productivity
was 87%.
Business
Segment Discussion
The
following provides
perspective on the
company’s July – September
results by business
segment.
Beauty
- The beauty business
delivered strong
volume, sales and
earnings growth.
Unit volume increased
seven percent, led
by growth in developing
markets. Growth was
led by hair care,
skin care, and feminine
care. The hair care
business was driven
by double digit growth
on Pantene, Head & Shoulders
and Rejoice. Skin
care and feminine
care both delivered
strong volume growth
behind double digit
growth on Olay, Always,
and Naturella. Net
sales increased seven
percent to $4.99
billion. Foreign
exchange added one
percent to sales
which was offset
by mix effects of
negative one percent
due to strong developing
market growth. Net
earnings increased
16 percent to $783
million driven by
strong top-line growth,
scale benefits and
savings from the
Wella integration.
This was partially
offset by increased
marketing spending
behind new product
launches such as
Lacoste Essentials,
Always Cottony Soft,
Naturella expansion
in Central and Eastern
Europe, Pantene Color
Expressions and Olay
Quench Hand & Body
lotion.
Family Health
- Health care delivered
a very strong quarter
of double digit volume,
sales and earnings
growth. Unit volume
increased 11 percent
behind the continued
success of Prilosec
OTC, Actonel and
oral care. Prilosec
OTC volume was up
more than double
the prior year level,
largely driven by
accelerated sales
ahead of the mid-September
price increase as
well as strong value
share growth versus
the prior year when
the product was on
allocation. Health
care net sales increased
13 percent to $2.08
billion. The carryover
impact of pricing
actions taken in
previous periods
in pharmaceuticals & personal
health and in pet
health & nutrition
added one percent
to sales growth.
Favorable exchange
rates also contributed
one percent to sales
growth. Net earnings
increased 37 percent
to $336 million.
The net earnings
increase resulted
from strong volume
growth, product mix
benefits, and a favorable
base period comparison.
- Baby care and
family care delivered
solid top-line results.
Unit volume increased
five percent with
balanced growth on
both businesses.
Volume growth was
driven behind initiatives
such as Charmin Mega-Roll
and Pampers Baby
Stages of Development.
Net sales increased
five percent to $3.00
billion including
a positive foreign
exchange impact of
one percent. Pricing
added one percent
to sales growth.
Mix reduced sales
growth by two percent
primarily behind
rapid growth in developing
markets and mid-tier
products such as
Bounty Basic. Earnings
increased four percent
to $320 million driven
by volume growth.
The benefits of cost
savings efforts and
pricing were offset
by higher commodity
costs and increases
in direct-to-consumer
marketing investments
in baby care.
Household Care
- The fabric and
home care business
posted strong top
and bottom-line growth
for the quarter.
Volume increased
eight percent behind
growth on Tide, Ariel,
Downy, and Dawn.
Growth was driven
by new initiatives
that began shipping
this quarter, such
as Tide with Febreze
and Dawn Direct Foam,
as well as the incremental
benefit of prior
year initiatives
such as Tide Coldwater,
Tide with a Touch
of Downy, Ariel Ion
Power Gel, Dawn Bleach
Alternative and Downy
Simple Pleasures.
Net sales increased
11 percent to $4.22
billion including
a one percent benefit
from favorable foreign
exchange. The benefit
of prior price increases
helped to offset
rising commodity
costs and increased
sales by two percent.
Net earnings increased
10 percent to $641
million behind the
impacts of volume
growth, pricing,
ongoing savings programs,
and foreign exchange
gains from developing
market currencies.
These benefits were
partially offset
by rising commodity
prices.
- Snacks and coffee
results were heavily
impacted by Hurricane
Katrina. Unit volume
declined seven percent
and sales were down
five percent to $706
million due to the
disruption of the
coffee business caused
by Hurricane Katrina
. Coffee price increases
taken last fiscal
year in response
to higher bean costs
added five percent
to sales growth.
Mix effects reduced
sales by three percent.
Net earnings were
$73 million, down
six percent driven
primarily by the
business disruption
and other damages
associated with Hurricane
Katrina.
Fiscal Year
and October - December
Quarter Guidance
For the 2006 fiscal
year, the company expects
net sales to grow 17
to 19 percent. This
includes 14 to 15 percent
growth resulting from
acquisitions and divestitures.
Foreign exchange rates
are expected to have
a negative impact on
sales growth of about
two percent. Pricing
and mix are expected
to contribute about
one percent to sales
growth. Organic sales,
which exclude the impacts
of acquisitions, divestitures,
and foreign exchange,
are expected to grow
five to six percent.
This is at the top
end of the company’s
previous guidance.
The company confirmed
its previous earnings
per share guidance
for the fiscal year
excluding Gillette
despite the impact
of the hurricanes and
higher energy and commodity
costs. The dilution
impact from the Gillette
acquisition on earnings
per share is expected
to be $0.20 to $0.26
for the fiscal year,
consistent with the
company’s previous
guidance. This includes
one time items which
are expected to be
nine to 12 cents per
share. In total, earnings
per share are expected
to be $2.54 to $2.60
for the fiscal year.
This includes the impact
of expensing stock
options, which the
company expects will
be about 11 cents per
share including Gillette.
For the October to
December quarter, the
company expects net
sales growth of 23
to 26 percent. This
includes 20 to 21 percent
growth from acquisitions
and divestitures. Foreign
exchange rates are
expected to have a
negative impact on
sales growth of about
two percent. Pricing
and mix are expected
to contribute one to
two percent to sales
growth. Organic sales,
which exclude the impacts
of acquisitions, divestitures,
and foreign exchange,
are expected to grow
five to seven percent.
Earnings per share
including Gillette
are expected to be
in the range of $0.66
to $0.69 for the quarter.
This includes the impact
of expensing stock
options, which the
company expects will
be about two cents
per share including
Gillette. Within this,
Gillette dilution is
expected to be $0.09
to $0.12 per share.
Forward Looking
Statements
All
statements, other
than statements of
historical fact included
in this release, are
forward-looking statements,
as that term is defined
in the Private Securities
Litigation Reform Act
of 1995. In addition
to the risks and uncertainties
noted in this release,
there are certain factors
that could cause actual
results to differ materially
from those anticipated
by some of the statements
made. These include:
(1) the ability to
achieve business plans,
including with respect
to lower income consumers
and growing existing
sales and volume profitably
despite high levels
of competitive activity,
especially with respect
to the product categories
and geographical markets
(including developing
markets) in which the
Company has chosen
to focus; (2) the ability
to successfully execute,
manage and integrate
key acquisitions and
mergers, including
(i) the Domination
and Profit Transfer
Agreement with Wella,
and (ii) the Company’s
merger with The Gillette
Company, and to achieve
the cost and growth
synergies in accordance
with the stated goals
of the Gillette transaction;
(3) the ability to
manage and maintain
key customer relationships;
(4) the ability to
maintain key manufacturing
and supply sources
(including sole supplier
and plant manufacturing
sources); (5) the ability
to successfully manage
regulatory, tax and
legal matters (including
product liability,
patent, and other intellectual
property matters),
and to resolve pending
matters within current
estimates; (6) the
ability to successfully
implement, achieve
and sustain cost improvement
plans in manufacturing
and overhead areas,
including the Company's
outsourcing projects;
(7) the ability to
successfully manage
currency (including
currency issues in
volatile countries),
debt (including debt
related to the Company’s
announced plan to repurchase
shares of the Company’s
stock), interest rate
and certain commodity
cost exposures; (8)
the ability to manage
the continued global
political and/or economic
uncertainty and disruptions,
especially in the Company's
significant geographical
markets, as well as
any political and/or
economic uncertainty
and disruptions due
to terrorist activities;
(9) the ability to
successfully manage
competitive factors,
including prices, promotional
incentives and trade
terms for products;
(10) the ability to
obtain patents and
respond to technological
advances attained by
competitors and patents
granted to competitors;
(11) the ability to
successfully manage
increases in the prices
of raw materials used
to make the Company's
products; (12) the
ability to stay close
to consumers in an
era of increased media
fragmentation; and
(13) the ability to
stay on the leading
edge of innovation.
For additional information
concerning factors
that could cause actual
results to materially
differ from those projected
herein, please refer
to our most recent
10-K, 10-Q and 8-K
reports.
About Procter & Gamble
Three
billion times a day,
P&G brands
touch the lives of
people around the world.
The company has one
of the strongest portfolios
of trusted, quality,
leadership brands,
including Pampers®,
Tide®, Ariel®, Always®,
Whisper®, Pantene®,
Mach3®, Bounty®, Dawn®,
Pringles®, Folgers®,
Charmin®, Downy®, Lenor®,
Iams®, Crest®, Oral-B®,
Actonel®, Duracell®,
Olay®, Head & Shoulders®,
Wella, Gillette®, and
Braun. The P&G
community consists
of almost 140,000 employees
working in over 80
countries worldwide.
Please visit http://www.pg.com for
the latest news and
in-depth information
about P&G and its
brands.
#
# #
P&G
Media Contact :
In
the US : 1 866-PROCTER
or 1 866 776 2837
International:
+ 00 1 513 945 9087
P&G
Investor Relations
Contact :
Chris
Peterson + 00 1 513
983 2414
The
Procter & Gamble
Company
Exhibit
1: Non-GAAP Measures
In
accordance with the
SEC’s Regulation G,
the following provides
definitions of the
non-GAAP measures used
in the earnings release
and the reconciliation
to the most closely
related GAAP measure.
Organic Sales Growth.
Organic sales growth
is a non-GAAP measure
of sales growth excluding
the impacts of acquisitions,
divestitures and foreign
exchange from year-over-year
comparisons. We believe
this provides investors
with a more complete
understanding of underlying
sales trends by providing
sales growth on a consistent
basis. The reconciliation
of reported sales growth
to organic sales growth:
| Total Sales Growth |
8% |
| Less: Foreign
Exchange Impact |
1% |
| Less: Acquisition/Divestiture
Impact |
-1% |
| Organic Sales
Growth |
8% |
OTHER MEASURES
Free
Cash Flow. Free
cash flow is defined
as operating cash flow
less capital spending.
We view free cash flow
as an important measure
because it is one factor
in determining the
amount of cash available
for dividends and discretionary
investment. Free cash
flow is also one of
the measures used to
evaluate senior management
and is a factor in
determining their at-risk
compensation.
Free
Cash Flow Productivity.
Free cash flow productivity
is defined as the ratio
of free cash flow to
net earnings. The company’s
long-term target is
to generate free cash
at or above 90 percent
of net earnings. Free
cash flow is also one
of the measures used
to evaluate senior
management.
The reconciliation
of free cash flow and
free cash flow productivity
is provided below :
| ($MM) |
Operating
Cash Flow |
Capital
Spending |
Free Cash Flow |
Net Earnings |
Free Cash Flow
Productivity |
| Jul-Sept '04 |
1,912 |
413 |
1,499 |
1,942 |
77% |
| Jul-Sept '05 |
2,171 |
401 |
1,770 |
2,029 |
87% |
Earnings
per Share Excluding
Prior Year Divestiture
Gains.
This is the EPS growth
in the September 2005
quarter relative to
the September 2004
quarter, excluding
the impact of divestiture
gains – namely the
juice divestiture gain
which was recorded
in the base period.
This measure is provided
in order to give perspective
on the company’s EPS
growth excluding the
impact of the gain
in the base period.
The reconciliation
of EPS growth and EPS
excluding prior year
divestiture gains growth
:
| Reported
July – September
2004 EPS |
$0.70 |
| Less: July –
September 2004
Divestiture Gain: |
$0.03 |
| July – September
2004 EPS Excluding
Divestiture Gain: |
$0.67 |
#
# #
|